These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27265447)

  • 1. Influenza vaccine effectiveness: Maintained protection throughout the duration of influenza seasons 2010-2011 through 2013-2014.
    Radin JM; Hawksworth AW; Myers CA; Ricketts MN; Hansen EA; Brice GT
    Vaccine; 2016 Jul; 34(33):3907-12. PubMed ID: 27265447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Exindari M; Gioula G; Pogka V; Malisiovas N; Mentis A
    Vaccine; 2015 Jan; 33(2):367-73. PubMed ID: 25448097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
    Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
    Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.
    Martínez-Baz I; Navascués A; Pozo F; Chamorro J; Albeniz E; Casado I; Reina G; Cenoz MG; Ezpeleta C; Castilla J;
    Hum Vaccin Immunother; 2015; 11(7):1626-33. PubMed ID: 25996366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants.
    Janjua NZ; Skowronski DM; De Serres G; Dickinson J; Crowcroft NS; Taylor M; Winter AL; Hottes TS; Fonseca K; Charest H; Drews SJ; Sabaiduc S; Bastien N; Li Y; Gardy JL; Petric M
    J Infect Dis; 2012 Jun; 205(12):1858-68. PubMed ID: 22492921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.
    Gherasim A; Pozo F; de Mateo S; Gamarra IA; García-Cenoz M; Vega T; Martínez E; Giménez J; Castrillejo D; Larrauri A;
    Vaccine; 2016 Apr; 34(20):2371-7. PubMed ID: 27020713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results.
    Belongia EA; Kieke BA; Donahue JG; Coleman LA; Irving SA; Meece JK; Vandermause M; Lindstrom S; Gargiullo P; Shay DK
    Vaccine; 2011 Sep; 29(38):6558-63. PubMed ID: 21767593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014.
    Pierse N; Kelly H; Thompson MG; Bissielo A; Radke S; Huang QS; Baker MG; Turner N;
    Vaccine; 2016 Jan; 34(4):503-509. PubMed ID: 26685091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent and cross-season protection of inactivated influenza vaccine against A(H1N1)pdm09 illness among young children: 2012-2013 case-control evaluation of influenza vaccine effectiveness.
    Fu C; Xu J; Lin J; Wang M; Li K; Ge J; Thompson MG
    Vaccine; 2015 Jun; 33(25):2917-21. PubMed ID: 25921713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
    Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
    Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match.
    Sullivan SG; Komadina N; Grant K; Jelley L; Papadakis G; Kelly H
    J Med Virol; 2014 Jun; 86(6):1017-25. PubMed ID: 24395730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza vaccine effectiveness in the tropics: moderate protection in a case test-negative analysis of a hospital-based surveillance population in Bangkok between August 2009 and January 2013.
    Levy JW; Simasathien S; Watanaveeradej V; Bhoomiboonchoo P; Fernandez S; Jarman RG; Klungthong C; Gibbons RV; Kerdpanich P; Piboonbanakit D; Chirabandhu T; Yoon IK
    PLoS One; 2015; 10(8):e0134318. PubMed ID: 26267430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010-13, United States.
    Cowling BJ; Feng S; Finelli L; Steffens A; Fowlkes A
    Vaccine; 2016 Jan; 34(1):61-6. PubMed ID: 26611200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study.
    Jiménez-Jorge S; Savulescu C; Pozo F; de Mateo S; Casas I; Ledesma J; Larrauri A; ;
    Vaccine; 2012 May; 30(24):3595-602. PubMed ID: 22472792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China.
    Yang P; Thompson MG; Ma C; Shi W; Wu S; Zhang D; Wang Q
    Vaccine; 2014 Sep; 32(41):5285-9. PubMed ID: 25092635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal influenza vaccine effectiveness estimates: Development of a parsimonious case test negative model using a causal approach.
    Lane CR; Carville KS; Pierse N; Kelly HA
    Vaccine; 2016 Feb; 34(8):1070-6. PubMed ID: 26795366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mid-season influenza vaccine effectiveness 2011-2012: a Department of Defense Global, Laboratory-based, Influenza Surveillance System case-control study estimate.
    MacIntosh VH; Tastad KJ; Eick-Cost AA
    Vaccine; 2013 Mar; 31(13):1651-5. PubMed ID: 23395733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.